Edgar Snyder & Associates®
A Law Firm Representing Injured People
Call Us Toll Free 24/7
Published on Apr 09, 2009 by Edgar Snyder

Oral Contraceptives Linked to Lupus Risk

A study has linked oral contraceptives to lupus

The use of oral contraceptives has been associated with incident systemic lupus erythematosus (SLE), according to a study published in the April issue of Arthritis Care & Research. Lupus is a chronic, usually life-long autoimmune disease.

Researchers examined data on over 1.7 million women ages 18 to 45, all of whom were taking combined estrogen and progestogen oral contraceptives. Scientists found that over an average eight-year span, 786 women had a first-time diagnosis of lupus. The risk was primarily limited to current users, women who had just started using contraception, and those using older first- and second-generation oral contraceptives as opposed to third-generation ones. In addition, oral contraceptives containing the highest dose of ethinyl estradiol – 50 mcg – were associated with the highest risk.

Lupus affects women more than men in a 9:1 ratio. SLE most often targets the joints, skin, kidneys, brain, lungs, heart, serosa and gastrointestinal tract and can be fatal. Researchers have called for further studies to identify women who are most vulnerable to developing lupus after taking oral contraception.

Sources: "Oral Contraceptives Linked to Higher Lupus Risk." Medpage Today. April 6, 2009.
"Lupus Clinical Overview." H. Michael Belmont, M.D. Medical Director, Hospital for Joint Diseases, New York University Medical Center.
Think you have a case?
Think you have a case?
Free Case Review
First Name
Last Name
Briefly describe your injuries

Recent News

Sep 28, 2016
Pittsburgh Police Beefing Up DUI Patrols in 2017
Sep 26, 2016
Gear Up, Cool Down, and Stay Safe While Riding This Fall
Sep 16, 2016
Fall and Winter Car Kit
Sep 16, 2016
A New Law May Be Coming for Drivers
Sep 16, 2016
Smartphone Apps for Drivers